Hierarchical Phosphorylation at N-Terminal Transformation-Sensitive Sites in c-Myc Protein Is Regulated by Mitogens and in Mitosis

References

• Alitalo, Κ., G. Ramsay, J. M. Bishop, S. O. Pfeifer, W. W. Colby, and A. D. Levinson. 1983. Identification of nuclear proteins encoded by viral and cellular myc oncogenes. Nature (London) 306:274–277.
   PubMedGoogle Scholar
• Alvarez, E., I. C. Northwood, F. A. Gonzalez, D. A. Latour, A. Seth, C. Abate, T. Curran, and R. J. Davis. 1991. Pro-Leu-Ser/Thr-Pro is a consensus primary sequence for substrate protein phosphorylation. J. Biol. Chem. 266:15277–15285.
   PubMed Web of Science ®Google Scholar
• Amin, C., A. J. Wagner, and N. Hay. 1993. Sequence-specific transactivation by myc and repression by max. Mol. Cell. Biol. 15:383–390.
   Google Scholar
• Bello-Fernandez, C., G. Packham, and J. L. Cleveland. 1993. The ornithine decarboxylase gene is a transcriptional target of c-Myc. Proc. Natl. Acad. Sci. 90:7804–7808.
   PubMed Web of Science ®Google Scholar
• Berberich, S. J., and M. D. Cole. 1992. Casein kinase II inhibits the DNA binding activity of Max homodimers, but not Myc/Max heterodimers. Genes Dev. 6:166–176.
   PubMed Web of Science ®Google Scholar
• Bhatia, K., K. Huppi, G. Spangler, D. Siwarski, R. Iyer, and I. Magrath. 1993. Point mutations in the c-Myc transactivation domain are common in Burkitt's lymphoma and mouse plasmacytomas. Nat. Genet. 5:56–61.
   PubMed Web of Science ®Google Scholar
• Blackwell, Τ. Κ., L. Kretzner, Ε. M. Blackwood, R. Ν. Eisenman, and H. Weintraub. 1990. Sequence-specific DNA binding by the c-myc protein. Science 251:1149–1151.
   Google Scholar
• Blackwood, E. M., and R. N. Eisenman. 1991. Max: a helix-loop- helix protein that forms a sequence-specific DNA-binding complex with Myc. Science 251:1211–1217.
   PubMed Web of Science ®Google Scholar
• Boulton, T. G., S. H. Nye, D. J. Robbins, N. Y. Ip, E. Radziejewska, S. D. Morgenbesser, R. A. DePinho, N. Panayotatos, M. Η. Cobb, and G. D. Yancopoulos. 1991. ERKs: a family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF. Cell 65:663–675.
   PubMed Web of Science ®Google Scholar
• Boyle, W. J., T. Smeal, L. H. K. Defize, P. Angel, J. R. Woodgett, M. Karin, and T. Hunter. 1991. Activation of protein kinase C decreases phosphorylation of c-Jun at sites that negatively regulate its DNA-binding activity. Cell 64:573–584.
   PubMed Web of Science ®Google Scholar
• Boyle, W. J., P. van der Greer, and T. Hunter. 1991. Phosphopep-tide mapping and phosphoamino acid analysis by two-dimensional separation on thin-layer cellulose plates. Methods Enzymol. 201:110–149.
   PubMed Web of Science ®Google Scholar
• Chen, R.-H., C. Sarnecki, and J. Blenis. 1992. Nuclear localization and regulation of erk- and rsk-encoded kinases. Mol. Cell. Biol. 12:915–927.
   PubMed Web of Science ®Google Scholar
• Dang, C. V. Personal communication.
   Google Scholar
• Dang, C. V., and W. F. M. Lee. 1988. Identification of the human c-myc nuclear translocation signal. Mol. Cell. Biol. 8:4048–4054.
   PubMed Web of Science ®Google Scholar
• de Vries-Smits, A. M. M., B. M. Burgering, S. J. Leevers, C. J. Marshall, and J. L. Bos. 1992. Involvement of p21 ras in activation of extracellular signal-regulated kinase 2. Nature (London) 357:602–604.
   PubMedGoogle Scholar
• Dulie, V., E. Lees, and S. I. Reed. 1992. Association of human cyclin E with a periodic Gl-S phase protein kinase. Science 257:1958–1961.
   PubMedGoogle Scholar
• Fang, F., and J. W. Newport. 1991. Evidence that the Gl-S and G2-M transitions are controlled by different cdc2 proteins in higher eukaryotes. Cell 66:731–742.
   PubMed Web of Science ®Google Scholar
• Farina, S. F., J. L. Huff, and T. J. Parsons. 1992. Mutations within the 5′ half of the avian retrovirus MC29 v-myc gene alter or abolish transformation of chicken embryo fibroblasts and macrophages. J. Virol. 66:2698–2708.
   PubMedGoogle Scholar
• Filardo, E. J., and E. H. Humphries. 1991. An avian retrovirus expressing chicken pp59c-myc possesses weak transforming activity that may be modulated by adjacent normal cell neighbors. J. Virol. 65:6621–6629.
   PubMedGoogle Scholar
• Fiol, C. J., A. Wang, R. W. Roeske, and P. J. Roach. 1990. Ordered multisite protein phosphorylation. J. Biol. Chem. 265:6061–6065.
   PubMedGoogle Scholar
• Frykberg, L., T. Graf, and B. Vennstrom. 1987. The transforming activity of the chicken c-myc gene can be potentiated by mutations. Oncogene 1:415–421.
   PubMedGoogle Scholar
• Gorman, C. M., L. F. Moffat, and Β. Η. Howard. 1982. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol. Cell. Biol. 2:1044–1051.
   PubMed Web of Science ®Google Scholar
• Gu, W., K. Bhatia, I. Magrath, C. Dang, and R. Dalla-Favera. 1994. Binding and suppression of the Myc transcriptional activation domain by pl07. Science 264:251–254.
   PubMedGoogle Scholar
• Gupta, S., A. S. Seth, and R. J. Davis. 1993. Transactivation of gene expression by Myc is inhibited by mutation at the phosphorylation sites Thr-58 and Ser-62. Proc. Natl. Acad. Sci. USA 90:3216–3220.
   PubMed Web of Science ®Google Scholar
• Hamann, U., A. Wenzel, R. Frank, and M. Schwab. 1991. The MYCN protein of human neuroblastoma cells is phosphorylated by casein kinase II in the central region and at serine 367. Oncogene 6:1745–1751.
   PubMedGoogle Scholar
• Hann, S. R., H. D. Abrams, L. R. Rohrschneider, and R. N. Eisenman. 1983. Proteins encoded by v-Myc and c-Myc oncogenes: identification and localization in acute leukemia transfor-mants and bursal lymphoma cell lines. Cell 34:789–798.
   PubMed Web of Science ®Google Scholar
• Hann, S. R., M. Dixit, R. C. Sears, and L. Sealy. Myc proteins differentially regulate transcription through a C/EBP enhancer sequence. Submitted for publication.
   Google Scholar
• Hann, S. R., and R. N. Eisenman. 1984. Proteins encoded by the human c-myc oncogene: differential expression in neoplastic cells. Mol. Cell. Biol. 4:2486–2497.
   PubMed Web of Science ®Google Scholar
• Hann, S. R., M. W. King, D. L. Bentley, C. W. Anderson, and R. N. Eisenman. 1988. A non-AUG translational initiation in C-Myc exon 1 generates an N-terminally distinct protein whose synthesis is disrupted in Burkitt's lymphomas. Cell 52:185–195.
   PubMed Web of Science ®Google Scholar
• Hann, S. R., K. Sloan-Brown, and G. D. Spotts. 1992. Translational activation of the non-AUG-initiated c-myc-1 protein at high cell densities due to methionine deprivation. Genes Dev. 6:1229–1240.
   PubMedGoogle Scholar
• Hateboer, G., H. Timmers, A. Rustgi, M. Billaud, L. van't Veer, and R. Bernards. 1993. TATA-binding protein and the retinoblastoma gene product bind to overlapping epitopes on c-Myc and adenovirus EIA protein. Proc. Natl. Acad. Sci. USA 90:8489–8493.
   PubMedGoogle Scholar
• Heinrickson, R. L. 1977. Applications of thermolysin in protein structural analysis. Methods Enzymol. 47:179–193.
   Google Scholar
• Henricksson, M., A. Bakardjiev, G. Klein, and B. Luscher. 1993. Phosphorylation sites mapping in the N-terminal domain of c-Myc modulate its transforming potential. Oncogene 8:3199–3209.
   PubMedGoogle Scholar
• Hihara, H., T. Shimizu, and H. Yamamoto. 1974. Establishment of tumor cells cultured from chickens with avian lymphoid leukosis. Natl. Inst. Anim. Health Q. 14:163–173.
   PubMedGoogle Scholar
• Hughes, K., B. J. Pulverer, P. Theocharous, and J. R. Woodgett. 1992. Baculovirus mediated expression and characterization of rat glycogen synthase kinase-3 beta, the mammalian homologue of the Drosophila melanogaster zeste-white homeotic gene product. Eur. J. Biochem. 203:305–311.
   PubMedGoogle Scholar
• Hunter, T., and M. Karin. 1992. The regulation of transcription by phosphorylation. Cell 70:375–387.
   PubMed Web of Science ®Google Scholar
• Kato, G. J., J. Barret, M. Villa-Garcia, and C. V. Dang. 1990. An amino-terminal c-myc domain required for neoplastic transformation activates transcription. Mol. Cell. Biol. 10:5914–5920.
   PubMed Web of Science ®Google Scholar
• Kmiecik, T. E., and D. Shalloway. 1987. Activation and suppression of pp60c-src transforming ability by mutation of its primary sites of phosphorylation. Cell 49:65–73.
   PubMed Web of Science ®Google Scholar
• Koff, A., A. Giordano, D. Desai, K. Yamashita, J. W. Harper, S. Elledge, T. Nishimoto, D. Morgan, B. R. Franza, and J. Roberts. 1992. Formation and activation of a cyclin E-cdk2 complex during the Gl phase of the human cell cycle. Science 257:1689–1694.
   PubMed Web of Science ®Google Scholar
• Kretzner, L., E. M. Blackwood, and R. N. Eisenman. 1992. Myc and max proteins possess distinct transcriptional activities. Nature (London) 359:426–429.
   PubMedGoogle Scholar
• Landschulz, W. H., P. F. Johnson, and S. L. Mcknight. 1988. The leucine zipper: a hypothetical structure common to a new class of DNA binding proteins. Science 240:1759–1764.
   PubMed Web of Science ®Google Scholar
• Luscher, B., E. Christenson, D. W. Litchfield, E. G. Krebs, and R. N. Eisenman. 1990. Myb DNA binding inhibited by phosphorylation at a site deleted during oncogenic activation. Nature (London) 344:517–522.
   PubMedGoogle Scholar
• Luscher, B., and R. N. Eisenman. 1990. New light on myc and myb. Part I. myc. Genes Dev. 4:2025–2035.
   PubMed Web of Science ®Google Scholar
• Luscher, B., and R. N. Eisenman. 1992. Mitosis specific phosphorylation of the nuclear oncoproteins myc and myb. J. Cell Biol. 118:775–784.
   PubMedGoogle Scholar
• Luscher, B., E. A. Kuenzel, E. G. Krebs, and R. N. Eisenman. 1989. Myc oncoproteins are phosphorylated by casein kinase II. EMBO J. 8:1111–1119.
   PubMedGoogle Scholar
• Lutterbach, B., and S. R. Hann. Unpublished data.
   Google Scholar
• Maheswaran, S., H. Lee, and G. Sonenshein. 1994. Intracellular association of the protein product of the c-myc oncogene with the TATA-binding protein. Mol. Cell. Biol. 14:1147–1152.
   PubMedGoogle Scholar
• Meek, D. W., and A. J. Street. 1992. Nuclear protein phosphorylation and growth control. Biochem. J. 287:1–15.
   PubMedGoogle Scholar
• Meyerson, M., G. H. Enders, C. L. Wu, L. K. Su, C. Gorka, C. Nelson, E. Harlow, and L. H. Tsai. 1992. A family of human cdc2-related kinases. EMBO J. 11:2909–2917.
   PubMed Web of Science ®Google Scholar
• Murre, C., P. S. McCaw, and D. Baltimore. 1989. A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins. Cell 56:777–783.
   PubMed Web of Science ®Google Scholar
• Norton, P. A., and J. M. Coffin. 1985. Bacterial β-galactosidase as a marker of Rous sarcoma virus gene expression and replication. Mol. Cell. Biol. 5:281–290.
   PubMedGoogle Scholar
• Ofir, R., V. J. Dwarki, D. Rashid, and I. M. Verma. 1990. Phosphorylation of the C-terminus of fos is required for transcriptional transrepression of the c-fos promoter. Nature (London) 348:80–82.
   PubMedGoogle Scholar
• Palmieri, S., P. Kahn, and T. Graf. 1983. Quail embryo fibroblasts transformed by four v-myc isolates show enhanced proliferation but are non-tumorigenic. EMBO J. 2:2385–2389.
   PubMed Web of Science ®Google Scholar
• Papas, T. S., and J. A. Lautenberger. 1985. Sequence curiosity in v-myc oncogene. Nature (London) 318:237.
   PubMedGoogle Scholar
• Pearson, R. B., and Β. Ε. Kemp. 1991. Protein kinase phosphorylation site sequences and consensus specificity motifs: tabulations. Methods Enzymol. 200:62–81.
   PubMed Web of Science ®Google Scholar
• Pulverer, B. J., C. Fisher, K. Vousden, T. Littlewood, G. Evan, and J. R. Woodgett. 1994. Site-specific modulation of c-myc cotransformation by residues phosphorylated in vivo. Oncogene 9:59–70.
   PubMed Web of Science ®Google Scholar
• Ramsay, G., M. J. Hayman, and K. Bister. 1982. Phosphorylation of specific sites in the gag-myc polyproteins encoded by MC29-type viruses correlates with their transforming ability. EMBO J. 9:1111–1116.
   Google Scholar
• Ramsay, G. M., G. Moscovici, C. Moscovici, and J. M. Bishop. 1990. Neoplastic transformation and tumorigenesis by the human protooncogene MYC. Proc. Natl. Acad. Sci. USA 87:2102–2106.
   PubMedGoogle Scholar
• Resar, L. M. S., C. Dolde, J. F. Barret, and C. V. Dang. 1993. B-Myc inhibits neoplastic transformation and transcriptional activation by c-Myc. Mol. Cell. Biol. 13:1130–1136.
   PubMedGoogle Scholar
• Reynolds, A. B., J. Vila, T. J. Lansing, W. M. Potts, M. J. Weber, and J. T. Parsons. 1987. Activation of the oncogenic potential of the avian cellular src protein by specific structural alteration of the carboxy terminus. EMBO J. 6:2359–2364.
   PubMed Web of Science ®Google Scholar
• Roach, P. J. 1991. Multisite and hierarchal protein phosphorylation. J. Biol. Chem. 266:14139–14142.
   PubMed Web of Science ®Google Scholar
• Rossomando, A. J., D. M. Payne, M. J. Weber, S. L. Pelech, and T. W. Sturgill. 1989. Evidence that pp42, a major tyrosine kinase target protein, is a mitogen-activated serine/threonine protein kinase. Proc. Natl. Acad. Sci. USA 86:6940–6943.
   PubMed Web of Science ®Google Scholar
• Roy, A., C. Carruthers, T. Gutjahr, and R. G. Roeder. 1993. Direct role for Myc in transcription initiation mediated by interactions with TFII-I. Nature (London) 365:359–361.
   PubMedGoogle Scholar
• Saksela, K., T. P. Makela, K. Hughes, J. R. Woodgett, and K. Alitalo. 1992. Activation of protein kinase C increases phosphorylation of the L-myc trans-activator domain at a GSK-3 target site. Oncogene 7:347–353.
   PubMedGoogle Scholar
• Sarid, J., T. D. Halazonetis, W. Murphy, and P. Leder. 1987. Evolutionarily conserved regions of the human c-myc protein can be uncoupled from transforming activity. Proc. Natl. Acad. Sci. USA 84:170–173.
   PubMedGoogle Scholar
• Seth, A., F. G. Gonzalez, S. Gupta, D. L. Raden, and R. J. Davis. 1992. Signal transduction within the nucleus by mitogen activated protein kinase. J. Biol. Chem. 267:24796–24804.
   PubMedGoogle Scholar
• Shrivastava, A., S. Saleque, G. V. Kalpana, S. Artandi, S. P. Goff, and K. Calarne. 1993. Inhibition of transcriptional regulator Yin-Yang-1 by association with c-Myc. Science 262:1889–1892.
   PubMedGoogle Scholar
• Smith, D., and K. Johnson. 1988. Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene 67:31–40.
   PubMed Web of Science ®Google Scholar
• Smith, D. R., B. Vennstrom, M. J. Hayman, and P. J. Enrietto. 1985. Nucleotide sequence of HBI, a novel recombinant MC29 derivative with altered pathogenic properties. J. Virol. 56:969–977.
   PubMedGoogle Scholar
• Spencer, C. A., and M. Groudine. 1991. Control of c-myc regulation in normal and neoplastic cells. Adv. Cancer Res. 56:1–48.
   PubMed Web of Science ®Google Scholar
• Spotts, G. D., and S. R. Hann. 1990. Enhanced translation and increased turnover of c-Myc proteins occur during differentiation of murine erythroleukemia cells. Mol. Cell. Biol. 10:3952–3964.
   PubMedGoogle Scholar
• Stone, J., T. de Lange, G. Ramsay, E. Jakobovits, J. M. Bishop, H. Varmus, and W. Lee. 1987. Definition of regions in human c-myc that are involved in transformation and nuclear localization. Mol. Cell. Biol. 7:1697–1709.
   PubMed Web of Science ®Google Scholar
• Street, A. J., E. Blackwood, B. Luscher, and R. N. Eisenman. 1990. Mutational analysis of the carboxy-terminal casein kinase II phosphorylation site in human c-myc. Curr. Top. Microbiol. Immunol. 166:251–258.
   PubMedGoogle Scholar
• Symonds, G., A. Hartshorn, A. Kennewell, M.-A. O'Mara, A. Bruskin, and J. M. Bishop. 1989. Transformation of murine myelomonocytic cells by myc: point mutations in v-myc contribute synergistically to transforming potential. Oncogene 4:285–294.
   PubMedGoogle Scholar
• Taparowsky, E. Personal communication.
   Google Scholar
• Tikhonenko, A., A.-R. Hartman, and M. Linial. 1993. Overproduction of v-Myc in the nucleus and its excess over Max are not required for avian fibroblast transformation. Mol. Cell. Biol. 13:3623–3631.
   PubMedGoogle Scholar
• van den Heuvel, S., and E. Harlow. 1993. Distinct roles for cyclin-dependent kinases in cell cycle control. Science 262:2050–2054.
   PubMed Web of Science ®Google Scholar
• Wigler, M., R. Sweet, G. K. Sim, B. Wold, A. Pellicer, E. Lacy, T. Maniatis, S. Silverstein, and R. Axel. 1979. Transformation of mammalian cells with genes from procaryotes and eucaryotes. Cell 16:777–785.
   PubMed Web of Science ®Google Scholar
• Woodgett, J. R. 1991. A common denominator linking glycogen metabolism, nuclear oncogenes and development. Trends Bio-chem. Sci. 16:177–181.
   PubMedGoogle Scholar